RTW Investments’s Novavax NVAX Stock Holding History

RTW Investments’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-239	Closed	-$996K	–	37
2016 Q3	$996K	Buy	+239	New	+$30.9K	0.3%	28

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RTW Investments's NVAX Position: Q4 2018 in Review

RTW Investments sold out of Novavax (NVAX) in Q4 2018, closing a stake of 138,551 shares — an estimated $5.21M sold.

RTW Investments first reported a position in NVAX in Q1 2018 and held it in 3 quarters. The position peaked at $5.73M in Q1 2018. 168 funds tracked by Wall St. Rank hold NVAX as of Q4 2018.

RTW Investments reported no remaining Novavax position as of Q4 2018 after selling out during the quarter.
RTW Investments sold 138,551 Novavax shares in Q4 2018, an estimated $5.21M.
RTW Investments first reported a position in Novavax in Q1 2018 and held it in 3 quarters.
RTW Investments's Novavax position peaked at $5.73M in Q1 2018.
168 funds tracked by Wall St. Rank held Novavax as of Q4 2018.

Based on RTW Investments's 13F filing for Q4 2018, filed 14 Feb 2019.